BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 25652516)

  • 21. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
    Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous optimization of RBE-weighted dose and nanometric ionization distributions in treatment planning with carbon ions.
    Burigo LN; Ramos-Méndez J; Bangert M; Schulte RW; Faddegon B
    Phys Med Biol; 2019 Jan; 64(1):015015. PubMed ID: 30523890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton and helium ion radiotherapy for meningioma tumors: a Monte Carlo-based treatment planning comparison.
    Tessonnier T; Mairani A; Chen W; Sala P; Cerutti F; Ferrari A; Haberer T; Debus J; Parodi K
    Radiat Oncol; 2018 Jan; 13(1):2. PubMed ID: 29316969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance and implementation of RBE variations in proton beam therapy.
    Paganetti H
    Technol Cancer Res Treat; 2003 Oct; 2(5):413-26. PubMed ID: 14529306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling secondary cancer risk ratios for proton versus carbon ion beam therapy: A comparative study based on the local effect model.
    Hufnagl A; Johansson G; Siegbahn A; Durante M; Friedrich T; Scholz M
    Med Phys; 2022 Aug; 49(8):5589-5603. PubMed ID: 35717591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spot-scanning hadron arc (SHArc) therapy: A proof of concept using single- and multi-ion strategies with helium, carbon, oxygen, and neon ions.
    Mein S; Kopp B; Tessonnier T; Liermann J; Abdollahi A; Debus J; Haberer T; Mairani A
    Med Phys; 2022 Sep; 49(9):6082-6097. PubMed ID: 35717613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Data-driven ion-independent relative biological effectiveness modeling using the beam quality Q.
    Tian L; Lühr A
    Phys Med Biol; 2023 May; 68(10):. PubMed ID: 37011630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive comparison of local effect model IV predictions with the particle irradiation data ensemble.
    Pfuhl T; Friedrich T; Scholz M
    Med Phys; 2022 Jan; 49(1):714-726. PubMed ID: 34766635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the dose-averaged LET a reliable predictor for the relative biological effectiveness?
    Grün R; Friedrich T; Traneus E; Scholz M
    Med Phys; 2019 Feb; 46(2):1064-1074. PubMed ID: 30565705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy of the local effect model for the prediction of biologic effects of carbon ion beams in vitro and in vivo.
    Elsässer T; Krämer M; Scholz M
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):866-72. PubMed ID: 18430521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mechanism-based approach to predict the relative biological effectiveness of protons and carbon ions in radiation therapy.
    Frese MC; Yu VK; Stewart RD; Carlson DJ
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):442-50. PubMed ID: 22099045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biophysical modeling and experimental validation of relative biological effectiveness (RBE) for
    Mein S; Dokic I; Klein C; Tessonnier T; Böhlen TT; Magro G; Bauer J; Ferrari A; Parodi K; Haberer T; Debus J; Abdollahi A; Mairani A
    Radiat Oncol; 2019 Jul; 14(1):123. PubMed ID: 31296232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity study of the microdosimetric kinetic model parameters for carbon ion radiotherapy.
    Dahle TJ; Magro G; Ytre-Hauge KS; Stokkevåg CH; Choi K; Mairani A
    Phys Med Biol; 2018 Nov; 63(22):225016. PubMed ID: 30418940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosimetric verification in water of a Monte Carlo treatment planning tool for proton, helium, carbon and oxygen ion beams at the Heidelberg Ion Beam Therapy Center.
    Tessonnier T; Böhlen TT; Ceruti F; Ferrari A; Sala P; Brons S; Haberer T; Debus J; Parodi K; Mairani A
    Phys Med Biol; 2017 Jul; 62(16):6579-6594. PubMed ID: 28650846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of RBE-Weighted Dose Models for Carbon Ion Therapy Toward Modernization of Clinical Practice at HIT: In Vitro, in Vivo, and in Patients.
    Mein S; Klein C; Kopp B; Magro G; Harrabi S; Karger CP; Haberer T; Debus J; Abdollahi A; Dokic I; Mairani A
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):779-791. PubMed ID: 32504659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose prescription in carbon ion radiotherapy: a planning study to compare NIRS and LEM approaches with a clinically-oriented strategy.
    Fossati P; Molinelli S; Matsufuji N; Ciocca M; Mirandola A; Mairani A; Mizoe J; Hasegawa A; Imai R; Kamada T; Orecchia R; Tsujii H
    Phys Med Biol; 2012 Nov; 57(22):7543-54. PubMed ID: 23104051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological Dose Optimization for Particle Arc Therapy Using Helium and Carbon Ions.
    Mein S; Tessonnier T; Kopp B; Schömers C; Harrabi S; Abdollahi A; Debus J; Haberer T; Mairani A
    Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):334-348. PubMed ID: 35490991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose prescription in carbon ion radiotherapy: How to compare two different RBE-weighted dose calculation systems.
    Molinelli S; Magro G; Mairani A; Matsufuji N; Kanematsu N; Inaniwa T; Mirandola A; Russo S; Mastella E; Hasegawa A; Tsuji H; Yamada S; Vischioni B; Vitolo V; Ferrari A; Ciocca M; Kamada T; Tsujii H; Orecchia R; Fossati P
    Radiother Oncol; 2016 Aug; 120(2):307-12. PubMed ID: 27394694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton and carbon ion beam treatment with active raster scanning method in 147 patients with skull base chordoma at the Heidelberg Ion Beam Therapy Center-a single-center experience.
    Mattke M; Ohlinger M; Bougatf N; Harrabi S; Wolf R; Seidensaal K; Welzel T; Röder F; Gerum S; Ellerbrock M; Jäkel O; Haberer T; Herfarth K; Uhl M; Debus J
    Strahlenther Onkol; 2023 Feb; 199(2):160-168. PubMed ID: 36149438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The increased biological effectiveness of heavy charged particles: from radiobiology to treatment planning.
    Krämer M; Weyrather WK; Scholz M
    Technol Cancer Res Treat; 2003 Oct; 2(5):427-36. PubMed ID: 14529307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.